粤万年青：股东合和投资拟减持不超过480万股

Group 1 - The core point of the article is that Hehe Investment plans to reduce its stake in Guangdong Wannianqing Pharmaceutical Co., Ltd. by up to 480 million shares, which is no more than 3% of the company's total share capital [1] - Guangdong Wannianqing's revenue composition for the year 2024 is as follows: pharmaceuticals account for 97.36%, other businesses for 1.53%, medical services and health management for 0.57%, and traditional Chinese medicine slices for 0.53% [1] - As of the report, Guangdong Wannianqing has a market capitalization of 2.9 billion yuan [1]